About Zinc finger protein 627
Zinc finger protein 627 (ZNF627) is a protein
from Homo sapiens identified by UniProt accession
Q7L945, 461 residues long.
MolForge cross-references it against 0 known binders and
17 disease associations.
Target properties
| Protein name | Zinc finger protein 627 |
| UniProt accession | Q7L945 |
| Gene | ZNF627 |
| Organism | Homo sapiens |
| Length | 461 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (17)
Diseases linked to this target (Open Targets).
- Spondyloenchondrodysplasia with immune dysregulation · score 0.57
- genetic disorder · score 0.47
- blood protein measurement · score 0.29
- neurodegenerative disease · score 0.16
- 3-hydroxypropylmercapturic acid measurement · score 0.10
- mean platelet volume · score 0.09
- myocardial infarction · score 0.02
- colorectal cancer · score 0.01
- medulloblastoma · score 0.01
- esophageal squamous cell carcinoma · score 0.01
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q7L945-F1 | alphafold | PREDICTED | 69.05 | — |
Amino-acid sequence (461 residues)
MDSVAFEDVA VNFTLEEWAL LDPSQKNLYR DVMRETFRNL ASVGKQWEDQ NIEDPFKIPR RNISHIPERL CESKEGGQGE ETFSQIPDGI LNKKTPGVKP CESSVCGEVG MGPSSLNRHI RDHTGREPNE YQEYGKKSYT RNQCGRALSY HRSFPVRERT HPGGKPYDCK ECGETFISLV SIRRHMLTHR GGVPYKCKVC GKAFDYPSLF RIHERSHTGE KPYECKQCGK AFSCSSYIRI HERTHTGDKP YECKQCGKAF SCSKYIRIHE RTHTGEKPYE CKQCGKAFRC ASSVRSHERT HTGEKLFECK ECGKALTCLA SVRRHMIKHT GNGPYKCKVC GKAFDFPSSF RIHERTHTGE KPYDCKQCGK AFSCSSSFRK HERIHTGEKP YKCTKCGKAF SRSSYFRIHE RTHTGEKPYE CKQCGKAFSR STYFRVHEKI HTGEKPYENP NPNASVVPVL S
Explore Zinc finger protein 627 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets